Bangalore, India, April 29, 2010

TIME named Kiran Mazumdar Shaw to the 2010 TIME 100, the magazine's annual list of the 100 most influential people in the world. The full list and related tributes appear in the May 10 issue of TIME, available on newsstands on Friday, April 30, and now at www.time.com/tk 

The list, now in its seventh year, recognizes the activism, innovation and achievement of the world’s most influential individuals. As Managing Editor Rick Stengel has said of the list in the past, "The TIME 100 is not a list of the most powerful people in the world, it’s not a list of the smartest people in the world, it's a list of the most influential people in the world. They're scientists, they're thinkers, they're philosophers, they're leaders, they're icons, they're artists, they're visionaries.  People who are using their ideas, their visions, their actions to transform the world and have an effect on a multitude of people."

Kiran Mazumdar Shaw said "TIME is an institution and it is a great honour to be a part of such an esteemed list, sharing the platform with luminaries from so many walks of life. It is a wonderful recognition."

Lance Armstrong, champion cyclist and the founder of LiveStrong, had this to say in his tribute to Kiran "When a parent is lost to cancer in the developing world, it means no school for the kids, no more food on the table and a future in which the only certainty is poverty. In 2010 we'll lose 8 million people as this disease quietly becomes the world's leading cause of death. And developing nations will keep getting hit the hardest.

Facing down this challenge is Dr. Kiran Mazumdar-Shaw. At age 25, she created a biotech company in her garage. Never mind that no one in the '70s knew what biotech was, that she is a woman and that backers were hard to come by because of these two points. Today that start-up, Biocon International, is a $1 billion operation.

Every year, Shaw donates $2 million to support health insurance coverage for 100,000 Indian villagers. She devoted $10 million to creating the 1,400-bed Mazumdar-Shaw Cancer Centre in Bangalore, India. When it opens this year, it will treat poor patients for free in the evenings so they can continue to work and care for their families during the day.

Thank you, Dr. Shaw, for treating cancer like the global crisis it has become."

About Biocon Limited
Established in 1978, Biocon Limited (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is India's largest biotechnology company by revenue. The Group, promoted by Ms Kiran Mazumdar-Shaw, is a fully-integrated, innovation-driven healthcare enterprise with strategic focus on biopharmaceuticals and research services. Biocon's value chain traverses the entire length of discovery, development and commercialization of novel therapeutics. With successful initiatives in clinical development, bio-processing and global marketing, Biocon delivers products and solutions to partners and customers in approximately 75 countries across the globe. Many of these products have USFDA and EMEA acceptance. Biocon’s robust product offering includes the world's first recombinant human insulin, INSUGEN(R)and India's first indigenously produced monoclonal antibody BIOMAb-EGFR(TM). For more information visit us at archive.biocon.com